title: Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential.
abstract: Among several promising new drug-delivery systems, liposomes represent an advanced technology to deliver active molecules to the site of action, and at present several formulations are in clinical use. Research on liposome technology has progressed from conventional vesicles ("first-generation liposomes") to "second-generation liposomes", in which long-circulating liposomes are obtained by modulating the lipid composition, size, and charge of the vesicle. Liposomes with modified surfaces have also been developed using several molecules, such as glycolipids or sialic acid. A significant step in the development of long-circulating liposomes came with inclusion of the synthetic polymer poly-(ethylene glycol) (PEG) in liposome composition. The presence of PEG on the surface of the liposomal carrier has been shown to extend blood-circulation time while reducing mononuclear phagocyte system uptake (stealth liposomes). This technology has resulted in a large number of liposome formulations encapsulating active molecules, with high target efficiency and activity. Further, by synthetic modification of the terminal PEG molecule, stealth liposomes can be actively targeted with monoclonal antibodies or ligands. This review focuses on stealth technology and summarizes pre-clinical and clinical data relating to the principal liposome formulations; it also discusses emerging trends of this promising technology.
authors: Dipartimento di Scienza eTecnologia del Farmaco, University of Turin, Turin, Italy. marialaura.immordino@unito.it
authors: Maria Laura
authors: ML
authors: Immordino
authors: Franco
authors: F
authors: Dosio
authors: Luigi
authors: L
authors: Cattel
mesh_terms: D004337:Drug Carriers / Q000737:chemistry*; D004339:Drug Compounding / Q000379:methods*; D005544:Forecasting; D008081:Liposomes / Q000737:chemistry*; D008956:Models, Chemical; D004364:Pharmaceutical Preparations / Q000008:administration & dosage* / Q000737:chemistry*
chemical_list: D004337:Drug Carriers; D008081:Liposomes; D004364:Pharmaceutical Preparations
references: Curr Opin Biotechnol. 2004 Dec;15(6):518-29
references: 15560978
references: J Magn Reson Imaging. 2002 Oct;16(4):362-77
references: 12353252
references: Curr Pharm Biotechnol. 2000 Sep;1(2):183-215
references: 11467336
references: MAGMA. 2005 Sep;18(4):186-92
references: 16155762
references: Gynecol Oncol. 2004 Apr;93(1):229-32
references: 15047241
references: Biochim Biophys Acta. 1993 Mar 14;1146(2):157-68
references: 8452853
references: Biosci Rep. 2002 Apr;22(2):225-50
references: 12428902
references: Biochim Biophys Acta. 1992 Jan 31;1103(2):198-204
references: 1543704
references: Pharm Res. 1997 Oct;14(10):1479-84
references: 9358565
references: Clin Pharmacokinet. 2005;44(4):331-47
references: 15828849
references: Int J Pharm. 2004 Feb 11;270(1-2):93-107
references: 14726126
references: Nat Biotechnol. 2005 Sep;23(9):1147-57
references: 16151408
references: Cancer. 2004 Mar 15;100(6):1199-207
references: 15022287
references: Semin Oncol. 2004 Dec;31(6 Suppl 13):53-90
references: 15717738
references: Biochim Biophys Acta. 1992 Jul 8;1108(1):40-8
references: 1643080
references: Immunology. 1995 Sep;86(1):64-70
references: 7590884
references: Proc Natl Acad Sci U S A. 1988 Sep;85(18):6949-53
references: 3413128
references: J Pharmacol Exp Ther. 1999 Feb;288(2):665-70
references: 9918573
references: Oncol Rep. 2005 Apr;13(4):589-95
references: 15756428
references: Breast. 2004 Jun;13(3):219-26
references: 15177425
references: Drugs R D. 2004;5(2):119-23
references: 15293876
references: Drug Dev Ind Pharm. 2005 Jan;31(2):223-9
references: 15773289
references: Biochim Biophys Acta. 1992 Feb 17;1104(1):95-101
references: 1550858
references: Biomaterials. 2001 Nov;22(22):3035-44
references: 11575478
references: Drug Deliv. 2004 Mar-Apr;11(2):123-8
references: 15200011
references: Eur J Pharm Biopharm. 2005 Jan;59(1):177-87
references: 15567316
references: Artif Cells Blood Substit Immobil Biotechnol. 2005;33(2):137-62
references: 15960077
references: J Pharmacol Exp Ther. 2001 Aug;298(2):607-12
references: 11454922
references: Adv Drug Deliv Rev. 2005 Apr 5;57(5):699-712
references: 15757756
references: Pharm Res. 2001 Jul;18(7):1042-8
references: 11496943
references: Anticancer Drugs. 2004 Jun;15(5):499-502
references: 15166625
references: J Biol Chem. 1992 Sep 15;267(26):18759-65
references: 1527006
references: Biochim Biophys Acta. 1993 Jul 25;1150(1):9-16
references: 8334142
references: J Clin Oncol. 2004 Oct 1;22(19):3916-21
references: 15459213
references: Br J Cancer. 2000 Sep;83(5):684-8
references: 10944612
references: J Pharm Sci. 2005 May;94(5):1024-38
references: 15793796
references: Ann Oncol. 2005 Feb;16(2):300-6
references: 15668288
references: J Clin Oncol. 2005 Mar 20;23(9):1859-66
references: 15699482
references: J Control Release. 2004 Aug 11;98(2):195-207
references: 15262412
references: Biochim Biophys Acta. 1981 Sep 24;665(3):538-45
references: 7295749
references: Pharm Res. 1994 Mar;11(3):402-6
references: 8008707
references: Biosci Rep. 2002 Apr;22(2):197-224
references: 12428901
references: J Control Release. 2000 Jan 3;63(1-2):19-30
references: 10640577
references: Arch Biochem Biophys. 1998 Sep 15;357(2):185-94
references: 9735159
references: Pharmacol Rev. 1999 Dec;51(4):691-743
references: 10581328
references: Biochim Biophys Acta. 1996 May 22;1281(1):31-7
references: 8652601
references: J Control Release. 2001 Jul 6;74(1-3):47-61
references: 11489482
references: Bioconjug Chem. 1998 Jul-Aug;9(4):418-50
references: 9667945
references: Br J Cancer. 2000 Jul;83(2):232-8
references: 10901376
references: Biochim Biophys Acta. 1994 Apr 20;1191(1):43-51
references: 8155683
references: J Leukoc Biol. 1986 Jan;39(1):1-12
references: 3455706
references: Ann Oncol. 2004 Mar;15(3):517-25
references: 14998859
references: Drugs Today (Barc). 2004 Feb;40(2):133-45
references: 15045035
references: Bioconjug Chem. 1994 Nov-Dec;5(6):493-6
references: 7873652
references: Semin Oncol. 2004 Dec;31(6 Suppl 13):36-52
references: 15717737
references: Cancer Res. 2003 Jun 15;63(12):3154-61
references: 12810643
references: Bioconjug Chem. 1999 Sep-Oct;10(5):703-7
references: 10502334
references: Prog Lipid Res. 2002 Sep;41(5):392-406
references: 12121719
references: Cancer Res. 2004 Nov 1;64(21):8002-8
references: 15520208
references: J Pharm Sci. 1995 Sep;84(9):1049-53
references: 8537880
references: J Control Release. 2001 Jul 10;75(1-2):83-91
references: 11451499
references: J Control Release. 2003 Sep 4;91(3):417-29
references: 12932719
references: J Immunol. 1981 May;126(5):1820-5
references: 7217669
references: Cancer. 2000 Sep 1;89(5):1037-47
references: 10964334
references: J Biol Chem. 1995 Oct 27;270(43):25845-9
references: 7592769
references: Blood. 2004 Sep 1;104(5):1442-9
references: 15155467
references: Cancer Res. 2000 Jul 1;60(13):3389-93
references: 10910044
references: Int J Pharm. 2000 Sep 15;205(1-2):101-8
references: 11000546
references: J Cancer Res Clin Oncol. 2003 Oct;129(10):549-55
references: 14513369
references: J Biol Chem. 2005 Apr 22;280(16):15619-27
references: 15695518
references: Vaccine. 1999 Mar 5;17(9-10):1223-38
references: 10195636
references: Crit Rev Ther Drug Carrier Syst. 1987;3(2):123-93
references: 3542245
references: Anticancer Res. 2005 Jul-Aug;25(4):3031-9
references: 16080562
references: J Control Release. 2004 Nov 5;100(1):135-44
references: 15491817
references: J Immunol. 1991 Jun 15;146(12):4234-41
references: 2040798
references: Biochim Biophys Acta. 1991 Jul 1;1066(1):29-36
references: 2065067
references: Cancer Chemother Pharmacol. 2004 May;53(5):452-7
references: 14749894
references: Cancer Sci. 2004 Jul;95(7):608-13
references: 15245599
references: Biochim Biophys Acta. 1992 Jul 27;1108(2):257-60
references: 1637850
references: Clin Cancer Res. 2002 Apr;8(4):1172-81
references: 11948130
references: Biochim Biophys Acta. 1994 Oct 12;1195(1):181-4
references: 7918561
references: Adv Drug Deliv Rev. 2005 Feb 28;57(4):637-51
references: 15722168
references: Semin Oncol. 2004 Dec;31(6 Suppl 13):147-60
references: 15717741
references: Crit Rev Ther Drug Carrier Syst. 1992;9(1):39-90
references: 1544174
references: J Pharm Sci. 1994 Apr;83(4):601-6
references: 8046623
references: Ann N Y Acad Sci. 1985;446:368-84
references: 2409883
references: Biochim Biophys Acta. 2001 Jun 6;1512(2):191-205
references: 11406096
references: J Control Release. 2005 Jul 20;105(3):305-17
references: 15908032
references: Nat Biotechnol. 1999 Aug;17(8):775-9
references: 10429242
references: J Liposome Res. 2001;11(2-3):153-64
references: 19530930
references: Biotechnol Prog. 2005 Jan-Feb;21(1):221-32
references: 15903261
references: J Pharm Pharm Sci. 2003 May-Aug;6(2):292-301
references: 12935441
references: J Cereb Blood Flow Metab. 2003 Aug;23(8):895-9
references: 12902833
references: Methods Enzymol. 2004;387:33-50
references: 15172156
references: Biochim Biophys Acta. 1994 Oct 12;1195(1):11-20
references: 7918551
references: Immunol Cell Biol. 2005 Apr;83(2):97-105
references: 15748206
references: Biochim Biophys Acta. 2003 Apr 1;1611(1-2):204-16
references: 12659962
references: Curr Opin Investig Drugs. 2001 Apr;2(4):488-95
references: 11566004
references: J Biol Chem. 1998 Jun 19;273(25):15621-7
references: 9624154
references: Cancer Res. 1993 Oct 15;53(20):4913-9
references: 8402681
references: Curr Opin Biotechnol. 2005 Feb;16(1):89-92
references: 15722020
references: Int J Cancer. 2004 Jan 10;108(2):301-6
references: 14639619
references: Oncologist. 2005 Mar;10(3):205-14
references: 15793224
references: J Control Release. 2003 Aug 28;91(1-2):123-33
references: 12932644
references: Cancer Res. 2003 Jan 1;63(1):86-92
references: 12517782
references: FEBS Lett. 1982 Aug 16;145(1):109-14
references: 6897042
references: Adv Drug Deliv Rev. 2005 Jun 17;57(9):1247-65
references: 15935873
references: Semin Oncol. 2004 Dec;31(6 Suppl 13):106-46
references: 15717740
references: Int J Cancer. 2004 Nov 20;112(4):693-700
references: 15382053
references: Curr Pharm Des. 2004;10(24):2981-9
references: 15379663
references: Anticancer Res. 2003 Jul-Aug;23(4):3341-5
references: 12926073
references: Ann Oncol. 2001 Apr;12(4):493-6
references: 11398881
references: Biochim Biophys Acta. 1993 Nov 7;1179(2):157-65
references: 8218358
references: Biochim Biophys Acta. 2002 Jan 2;1558(1):1-13
references: 11750259
references: Cancer Biol Ther. 2006 Jan;5(1):89-96
references: 16357513
references: Adv Genet. 2005;54:315-37
references: 16096017
references: Proc Natl Acad Sci U S A. 1978 Jun;75(6):2959-63
references: 208079
references: Semin Oncol. 2004 Dec;31(6 Suppl 13):5-15
references: 15717735
references: Int J Cancer. 1999 Mar 1;80(5):723-30
references: 10048974
references: Prog Lipid Res. 2003 Nov;42(6):463-78
references: 14559067
references: Cancer Res. 2000 Dec 15;60(24):6942-9
references: 11156394
references: J Liposome Res. 2004;14(3-4):155-73
references: 15676124
references: J Biol Chem. 1990 Mar 25;265(9):5226-31
references: 2318890
references: Biochim Biophys Acta. 1989 May 19;981(1):27-35
references: 2719971
references: Biochim Biophys Acta. 1999 Jul 15;1419(2):325-34
references: 10407083
references: Crit Rev Ther Drug Carrier Syst. 1990;6(4):315-65
references: 2186872
references: Biotechnol Prog. 2005 Jan-Feb;21(1):205-20
references: 15903260
references: Drugs R D. 1999 Feb;1(2):181-3
references: 10566021
references: Prog Lipid Res. 2003 Sep;42(5):439-62
references: 12814645
references: Pharmacol Ther. 1993 Nov;60(2):215-34
references: 8022858
references: J Biomater Sci Polym Ed. 2000;11(12):1307-17
references: 11261873
references: J Control Release. 2004 Jul 23;98(1):87-95
references: 15245892
references: Methods Enzymol. 2005;391:163-76
references: 15721380
references: Lung Cancer. 2001 Dec;34(3):427-32
references: 11714540
references: Adv Drug Deliv Rev. 2003 Sep 26;55(10):1261-77
references: 14499706
references: Pharm Res. 2002 Oct;19(10):1430-8
references: 12425459
references: Br J Cancer. 2001 Jan;84(2):157-63
references: 11161370
references: Biochim Biophys Acta. 2001 Jul 2;1513(1):25-37
references: 11427191
references: Bioconjug Chem. 2003 Nov-Dec;14(6):1156-64
references: 14624629
references: Cancer Chemother Pharmacol. 2004 Apr;53(4):329-36
references: 14673619
references: Adv Drug Deliv Rev. 2000 Mar 30;41(2):135-46
references: 10699310
references: J Clin Oncol. 2005 May 20;23(15):3495-501
references: 15908659
references: Methods Enzymol. 2005;391:145-62
references: 15721379
references: Curr Mol Med. 2004 Sep;4(6):681-9
references: 15357216
references: Biochim Biophys Acta. 1994 Jun 1;1192(1):35-44
references: 8204648